Home Applications 204803 Application 204803
Type NDA
Sponsor DURECT CORP Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 POSIMIR BUPIVACAINE INJECTABLE;INJECTION 132MG/ML Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N204803-001 POSIMIR BUPIVACAINE 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD 2021-02-01
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N204803-001 11400019 2041-01-12 Drug product 2022-09-01 N204803-001 11771624 2041-01-12 U-3724 2023-11-02
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD 2021-02-01 84e616aacf4f…2026-08-18 06:07:40 2026-07 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD 2021-02-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD 2021-02-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD 2021-02-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD 2021-02-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD 2021-02-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD 2021-02-01 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD 2021-02-01 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD 2021-02-01 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD, RS 2021-02-01 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD, RS 2021-02-01 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD, RS 2021-02-01 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD 2021-02-01 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD 2021-02-01 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD 2021-02-01 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD 2021-02-01 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD 2021-02-01 87673890dc5c…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE / INFILTRATION RLD, RS 2021-02-01 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N204803-001 POSIMIR 660MG/5ML (132MG/ML) SOLUTION / INFILTRATION RLD 2021-02-01 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 5 · 178 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N204803-001 11400019 2041-01-12 Drug product 2022-09-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N204803-001 11771624 2041-01-12 U-3724 2023-11-02 84e616aacf4f…2026-08-18 06:07:40 2026-07 N204803-001 11400019 2041-01-12 Drug product 2022-09-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204803-001 11771624 2041-01-12 U-3724 2023-11-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N204803-001 11400019 2041-01-12 Drug product 2022-09-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204803-001 11771624 2041-01-12 U-3724 2023-11-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204803-001 8153149 2025-09-15 Drug product 2021-03-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204803-001 8153661 2025-09-15 U-3074 2021-03-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204803-001 8753665 2025-09-15 U-3074 Drug product 2021-03-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204803-001 8846072 2025-09-15 U-3074 Drug product 2021-03-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204803-001 11400019 2041-01-12 Drug product 2022-09-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204803-001 11771624 2041-01-12 U-3724 2023-11-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N204803-001 8153149 2025-09-15 Drug product 2021-03-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204803-001 8153661 2025-09-15 U-3074 2021-03-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204803-001 8753665 2025-09-15 U-3074 Drug product 2021-03-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204803-001 8846072 2025-09-15 U-3074 Drug product 2021-03-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204803-001 11400019 2041-01-12 Drug product 2022-09-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204803-001 11771624 2041-01-12 U-3724 2023-11-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204803-001 8153149 2025-09-15 Drug product 2021-03-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204803-001 8153661 2025-09-15 U-3074 2021-03-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204803-001 8753665 2025-09-15 U-3074 Drug product 2021-03-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204803-001 8846072 2025-09-15 U-3074 Drug product 2021-03-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204803-001 11400019 2041-01-12 Drug product 2022-09-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204803-001 11771624 2041-01-12 U-3724 2023-11-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204803-001 8153149 2025-09-15 Drug product 2021-03-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204803-001 8153661 2025-09-15 U-3074 2021-03-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204803-001 8753665 2025-09-15 U-3074 Drug product 2021-03-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204803-001 8846072 2025-09-15 U-3074 Drug product 2021-03-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204803-001 11400019 2041-01-12 Drug product 2022-09-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204803-001 11771624 2041-01-12 U-3724 2023-11-02 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204803-001 8153149 2025-09-15 Drug product 2021-03-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204803-001 8153661 2025-09-15 U-3074 2021-03-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204803-001 8753665 2025-09-15 U-3074 Drug product 2021-03-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204803-001 8846072 2025-09-15 U-3074 Drug product 2021-03-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204803-001 11400019 2041-01-12 Drug product 2022-09-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204803-001 11771624 2041-01-12 U-3724 2023-11-02 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204803-001 8153149 2025-09-15 Drug product 2021-03-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204803-001 8153661 2025-09-15 U-3074 2021-03-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204803-001 8753665 2025-09-15 U-3074 Drug product 2021-03-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204803-001 8846072 2025-09-15 U-3074 Drug product 2021-03-02 2680178bc6a6…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 49396-6601 POSIMIR Bupivacaine Renaissance Lakewood, LLC NDA Current 51715-660 POSIMIR bupivacaine INNOCOLL PHARMACEUTICALS NDA Current 51715-660 POSIMIR bupivacaine INNOCOLL PHARMACEUTICALS NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 71731 SUPPL 2022-08-05 71720 SUPPL 2022-08-04 71163 ORIG 2022-05-31 66072 ORIG 2021-02-03 66054 ORIG 2021-02-02